Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @SetteGo
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SetteGo
-
An honor to be recognized alongside some amazing women communicators! Thank you to
@PRNews for the recognition, my team@VergeScientific for your partnership and our clients for inspiring us each day.https://twitter.com/VergeScientific/status/1222208052033662976 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great perspective on drug pricing and the potential impact of proposed legislation on biotech innovation.https://twitter.com/LifeSciVC/status/1204374845590556672 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Will poor trading performance of recent IPOs in other industries impact life sci IPOs?https://twitter.com/rcurtisspalding/status/1179738368101568512 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Lissette Steele proslijedio/la je Tweet
“Our mission was to take all the data that has been generated since the genome was sequenced and use protein degradation to provide a best-in-class solution to underserved patients,” said
@KymeraTx CSO and founder@NelloMainolfi.#Fierce15https://www.fiercebiotech.com/special-report/fiercebiotech-s-2019-fierce-15 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to
@NelloMainolfi and the fierce team at@KymeraTx!@FierceBiotech#fierce15#clienthttps://twitter.com/KymeraTx/status/1176120916117544961 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lissette Steele proslijedio/la je Tweet
After David Fajgenbaum suffered repeated life-threatening relapses of Castleman disease, he became laser-focused on trying to save his own life. He pioneered a new treatment and an approach to drug research that could help others with rare diseaseshttps://cnn.it/30nAtEk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great piece by
@AMahadevia for companies navigating growth. Love the working definition of scalable players, people who can grow with an organization. The mismatch is always the more challenging but critical piece.https://twitter.com/LifeSciVC/status/1169555886655848448 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Love this so much! After weeks of work building our boat, our
@NCC Youth team at the Lake Anne Cardboard Boat Regatta for the win in their heat! Go team!#soproudpic.twitter.com/HYFnxigc8pHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big news today! Could not be more thrilled to welcome
@aksellers to@VergeScientific as Partner and Head of Client Services, accelerating the growth of both our firm and our work to drive value for clients through strategic communications.https://www.vergescientific.com/verge-team/partner/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lissette Steele proslijedio/la je Tweet
50 years ago, this was the front page of
@NYTimes -- read the story behind the story here: https://nyti.ms/32E5K85 pic.twitter.com/sXdtp1WvHp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Awesome time with our
@NCC Youth group prepping for the annual@LakeAnne_Plaza cardboard boat regatta. Initial framework in place! Just three more weekends ‘til the big day!pic.twitter.com/e1OEJASZhX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lissette Steele proslijedio/la je Tweet
Something I taught my 10 yo son and his friend today: The way most people who are really good at something got so good at it was by (a) caring a lot about it and (b) practicing a lot.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lissette Steele proslijedio/la je Tweet
Kudos to
@statnews for publishing this thoughtful and poignant piece. Demonstrating the best of what that publication does to inform debate intelligently.https://www.statnews.com/2019/05/31/spinal-muscular-atrophy-zolgensma-price-critics/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Rules, New Way. We recently had the pleasure of working on
@kymeratx’s new website, bringing the story of the company’s science, novel approach and technology to life - a site also infused with perspectives from the people who make it all possible. http://www.kymeratx.com https://twitter.com/VergeScientific/status/1133825286439690242 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lissette Steele proslijedio/la je Tweet
Today Akero announced that the IND for our Phase 2a clinical study of FGF21 analog AKR-001 in NASH has been cleared by the FDA and we have screened our first patient! http://ow.ly/UYZJ50usjAH
#nash#biopharma#drugdevelopmentpic.twitter.com/xtgD86fIaD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fascinating profile piece. Nobel Prize winning chemist Frances Arnold "turns microbes into living factories" https://nyti.ms/2YP330J
#drugdiscovery#womeninscienceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Lissette Steele proslijedio/la je Tweet
Seeking an edge in the competitive market for cancer drugs, an industry giant is taking a bold but risky approach: targeting early stages of the disease https://www.wsj.com/articles/drug-giant-tries-new-tactic-to-fight-cancer-11558958400?shareToken=st40d3f6fe0edd4f6385cfbe913c560457 … via
@WSJ@deniserolandHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Not sure if you’ve seen this
@MarekDziubinski. Pretty cool.https://twitter.com/skathire/status/1132254191391510528 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.